Ultra-High-Throughput Structure-Based Virtual Screening for Small Molecule Inhibitors of Protein-Protein Interactions

被引:38
作者
Johnson, David K. [1 ]
Karanicolas, John [1 ,2 ]
机构
[1] Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66045 USA
[2] Univ Kansas, Dept Mol Biosci, 2030 Becker Dr, Lawrence, KS 66045 USA
基金
美国国家科学基金会;
关键词
PHARMACOPHORE-BASED DISCOVERY; DRUG DISCOVERY; RATIONAL DESIGN; HIV-1; INTEGRASE; LIGAND DOCKING; RECEPTOR; TARGETS; DATABASE; CONFORMATIONS; FLEXIBILITY;
D O I
10.1021/acs.jcim.5b00572
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein-protein interactions play important roles in virtually all cellular processes, making them enticing targets for modulation by small-molecule therapeutics: specific examples have been well validated in diseases ranging from cancer and autoimmune disorders, to bacterial and viral infections. Despite several notable successes, however, overall these remain a very challenging target class. Protein interaction sites are especially challenging for computational approaches, because the target protein surface often undergoes a conformational change to enable ligand binding: this confounds traditional approaches for virtual screening. Through previous studies, we demonstrated that biased "pocket optimization" simulations could be used to build collections of low-energy pocket-containing conformations, starting from an unbound protein structure. Here, we demonstrate that these pockets can further be used to identify ligands that complement the protein surface. To do so, we first build from a given pocket its "exemplar": a perfect, but nonphysical, pseudoligand that would optimally match the shape and chemical features of the pocket. In our previous studies, we used these exemplars to quantitatively compare protein surface pockets to one another. Here, we now introduce this exemplar as a template for pharmacophore-based screening of chemical libraries. Through a series of benchmark experiments, we demonstrate that this approach exhibits comparable performance as traditional docking methods for identifying known inhibitors acting at protein interaction sites. However, because this approach is predicated on ligand/exemplar overlays, and thus does not require explicit calculation of protein-ligand interactions, exemplar screening provides a tremendous speed advantage over docking: 6 million compounds can be screened in about 15 min on a single 16-core, dual-GPU computer. The extreme speed at which large compound libraries can be traversed easily enables screening against a "pocket-optimized" ensemble of protein conformations, which in turn facilitates identification of more diverse classes of active compounds for a given protein target.
引用
收藏
页码:399 / 411
页数:13
相关论文
共 89 条
[1]   Simplified Receptor Based Pharmacophore Approach to Retrieve Potent PTP-LAR Inhibitors Using Apoenzyme [J].
Ajay, Dara ;
Sobhia, M. Elizabeth .
CURRENT COMPUTER-AIDED DRUG DESIGN, 2011, 7 (03) :159-172
[2]  
[Anonymous], 2015, DASS SYST BIOVIA DIS
[3]  
[Anonymous], 2013, Omega
[4]  
[Anonymous], 2013, FASTROCS 3 2 0 4
[5]  
[Anonymous], 2013, ROCS 3 2 0 3
[6]   Hot-spots-guided receptor-based pharmacophores (HS-Pharm): A knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores [J].
Barillari, Caterina ;
Marcou, Gilles ;
Rognan, Didier .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (07) :1396-1410
[7]   Enhancements to the Rosetta Energy Function Enable Improved Identification of Small Molecules that Inhibit Protein-Protein Interactions [J].
Bazzoli, Andrea ;
Kelow, Simon P. ;
Karanicolas, John .
PLOS ONE, 2015, 10 (10)
[8]   32-indolyl ether derivatives of ascomycin: Three-dimensional structures of complexes with FK506-binding protein [J].
Becker, JW ;
Rotonda, J ;
Cryan, JG ;
Martin, M ;
Parsons, WH ;
Sinclair, PJ ;
Wiederrecht, G ;
Wong, F .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) :2798-2804
[9]   The ChEMBL bioactivity database: an update [J].
Bento, A. Patricia ;
Gaulton, Anna ;
Hersey, Anne ;
Bellis, Louisa J. ;
Chambers, Jon ;
Davies, Mark ;
Krueger, Felix A. ;
Light, Yvonne ;
Mak, Lora ;
McGlinchey, Shaun ;
Nowotka, Michal ;
Papadatos, George ;
Santos, Rita ;
Overington, John P. .
NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) :D1083-D1090
[10]   Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models [J].
Bohacek, Regine ;
Boosalis, Michael S. ;
McMartin, Colin ;
Faller, Douglas V. ;
Perrine, Susan P. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (05) :318-328